PCR-based comprehensive genomic profiling (PCR-CGP): Feasibility from >20,000 tumor tissue specimens (TTS) and predicted impact on actionable biomarker identification versus hybrid capture (H)-CGP and plasma (P)-CGP.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Dan Rhodes, Daniel H Hovelson, Jennifer Marie Suga, Daniel M. Anderson, Elizabeth Claire Dees, Han A. Koh, Mark E. Burkard, Jamil Khatri, Malek M. Safa, Marc Ryan Matrana, Eddy Shih-Hsin Yang, Alex R. Menter, Benjamin Marshall Parsons, Jennifer Nadine Slim, Jayson Falkner, Travis Reeder, Hana Vakil, Kat Kwiatkowski, Bryan Johnson, Scott A. Tomlins, Strata Network Investigators
Institutions: Strata Oncology (United States), Kaiser Permanente, Kaiser Permanente Vallejo Medical Center, Regions Hospital, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Christiana Care Health System, Christiana Hospital, Kettering Medical Center, Ochsner Medical Center, University of Alabama at Birmingham, Gundersen Health System, MultiCare Auburn Medical Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3032045684